×
Affiliated Organizations
  HN Medical Partners   School of Nursing   HNH Fitness   Villa Marie Claire   Simulation Learning   Haiti Health Promise
Medical Partners Offices
Cardiovascular Specialists University Orthopaedic Pulmonary Specialists Obstetrics & Gynecology North Jersey Heart North Jersey Surgical Surgical Specialistss Primary Care Specialty Assoc. Urologic Specialties Women's Health Care

List of Clinical Studies

  201-541-6312    |      clinicalresearch@holyname.org

Multiple Sclerosis

Study Name Principal Investigator
TG1101-RMS303 – An Open Label Extension Study of Ublituximab in Subjects with Relapsing MS.
Read more.
Mary Ann Picone, MD
MSPT– Feasibility of the multiple sclerosis performance test for assessment of functional performance measures in patients with multiple sclerosis.
Read more.
Mary Ann Picone, MD
WA25046– A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis.
Read more.
Mary Ann Picone, MD
RPC-1063-MS-001 – A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063).
Read more.
Mary Ann Picone, MD
RPC-1063-MS-010 – A Phase 3B, Multicenter, Open-Label Study to Evaluate the Immune Response to, and then Safety of, Vaccines in Participants with Relapsing Forms of Multiple Sclerosis who Receive Oral Ozanimod Compared to Non-Pegylated Interferon-ß or No Disease Modifying Therapy.
Read more.
Mary Ann Picone, MD
GN41791 – A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared with Ocrelizumab in Adult Patients with Primary Progressive Multiple Sclerosis (FENtrepid).
Read more.
Asya Wallach, MD